CATALOGO DEI PRODOTTI DELLA RICERCA

PALMIERI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.499
EU - Europa 3.179
AS - Asia 922
OC - Oceania 8
SA - Sud America 8
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.469
GB - Regno Unito 1.658
CN - Cina 806
IT - Italia 307
SE - Svezia 245
FR - Francia 233
FI - Finlandia 210
IE - Irlanda 196
DE - Germania 181
UA - Ucraina 67
TR - Turchia 42
BE - Belgio 31
CA - Canada 25
VN - Vietnam 16
KR - Corea 15
IR - Iran 14
NL - Olanda 11
IN - India 10
RU - Federazione Russa 10
AU - Australia 7
BR - Brasile 6
ES - Italia 5
MX - Messico 5
PL - Polonia 5
CZ - Repubblica Ceca 4
JP - Giappone 4
SA - Arabia Saudita 4
TH - Thailandia 3
AT - Austria 2
BO - Bolivia 2
CH - Svizzera 2
ID - Indonesia 2
MD - Moldavia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.618
Salva come PNG Salva come JPEG
Città #
Southend 1.547
Chandler 604
Jacksonville 561
Woodbridge 369
Ann Arbor 343
Houston 210
Dublin 195
Verona 141
Ashburn 138
Beijing 130
Wilmington 120
Nanjing 110
New York 98
Lawrence 86
Princeton 86
Jinan 75
Helsinki 60
Shenyang 59
Changsha 45
Phoenix 45
Hebei 43
Venice 41
Tianjin 39
Zhengzhou 39
Falls Church 32
Brussels 30
Düsseldorf 30
Haikou 30
Boardman 28
Sindelfingen 27
Jiaxing 25
Ningbo 25
Redmond 24
Nanchang 23
Hangzhou 22
Redwood City 21
Norwalk 20
Milan 19
Taizhou 19
Guangzhou 16
Auburn Hills 15
Augusta 15
Seoul 14
Seattle 13
San Mateo 11
Taiyuan 11
Fairfield 10
Fuzhou 10
Lanzhou 10
San Francisco 10
Dong Ket 9
Philadelphia 9
Toronto 9
Dearborn 8
Los Angeles 8
Mestre 8
Leawood 7
Montréal 7
Ardabil 6
Detroit 6
Elora 6
London 6
San Diego 6
Monmouth Junction 5
Mumbai 5
San Giovanni Ilarione 5
Washington 5
Andover 4
Cleveland 4
Cuauhtémoc 4
Cambridge 3
Chions 3
Clearwater 3
Edinburgh 3
Riyadh 3
Tappahannock 3
Tokyo 3
Warsaw 3
Amsterdam 2
Carate Brianza 2
Caserta 2
Chisinau 2
Cooperstown 2
Groningen 2
Kashan 2
Lappeenranta 2
Lissone 2
Madrid 2
Manchester 2
Markham 2
Munich 2
Pisa 2
Riva 2
Rome 2
Sacramento 2
Sandrigo 2
Sestri Ponente 2
Stockholm 2
Sucre 2
Vienna 2
Totale 5.889
Salva come PNG Salva come JPEG
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 213
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 156
Secretome protein signature of human pancreatic cancer stem-like cells 153
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 131
Pancreatic cancer stem cells characterization and secretome analysis 130
SHOTGUN PROTEOMIC ANALYSIS OF PANCREATIC CANCER STEM CELLS 129
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 129
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 126
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 122
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 121
Protein synthesis inhibitors cycloheximide and anisomycin induce interleukin-6 gene expression and activate transcription factor NF-kappa-B 120
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 116
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 115
Nuclear factor kappa-B (NF-kappa-B), nuclear factor interleukin-6 (NFIL-6 or C/EBP-beta) and nuclear factor interleukin-6-beta (NFIL6-beta or C/EBP-delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell 113
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 113
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 109
Cell-specific differences in the regulation of IL-6 expression by PMA 107
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 107
Bovine seminal ribonuclease precursor synthesized in vitro 104
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 104
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 104
Regulation of miR-23b expression and its dual role on ROS production and tumour development 103
Nuclear factor kB, nuclear factor interleukin-6 (NFIL6 or C/EBPbeta) and nuclear factor interleukin-6beta (NFIL6beta or C/EBPdelta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6 expressing human breast carcinoma cell line. 101
Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways 101
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 100
Protein-DNA interactions in the 5'-flanking region of the bovine pancreatic ribonuclease gene 99
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 99
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 98
A Qß DNA-containing hybrid plasmid giving rise to Qß phage formation in the bacterial host. 98
A Qbeta DNA-containing hybrid plasmid giving rise to Qbeta phage formation in the bacterial host [proceedings] 97
Lithostathine messenger RNA expression in different types of chronic pancreatitis. 97
How much is secondary structure responsible for resistance of double-stranded RNA to pancreatic ribonuclease A? 96
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 96
Proteomics in pancreatic cancer research. 95
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 95
Repression of the IL-6 gene is associated with hypermethylation. 94
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 94
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 93
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 93
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells 92
Expression of opioid genes in bovine seminal vesicles. 91
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 91
[Endonucleolytic mechanism of degradation of double-helix RNA by ribonuclease BS-1 and by ribonuclease A aggregates] 90
Differential, structure-dependent susceptibily of poli(A) and RNA to monomeric and dimeric pancreatic ribonuclease A. 88
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 87
The differential pattern of tissue specific expression of ruminant pancreatic type ribonucleases may help to understand the evolutionary history of their genes. 86
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 84
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 83
A pancreatic-like ribonuclease is synthesized in rat brain 82
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 82
Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. 81
Sequence analysis of a cloned cDNA coding for bovine seminal ribonuclease 80
UCP2, a mitochondrial protein regulated at multiple levels 76
The metabolic landscape of cancer stem cells 75
[Influence of the ionic strength on the effect of monomeric and dimeric RNAse on poly(A)] 74
GAAP-1: A transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity 74
In vitro synthesis of pig pancreas ribonuclease. 74
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 73
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 73
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 73
Genomic footprinting: detection of putative regulatory proteins in the promoter region of the interferon-alpha-1 gene in normal human tissues. 71
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 71
Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. 71
Sequences related to the ox pancreatic ribonuclease coding region in the genomic DNA of mammalian species 70
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 69
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 68
[Relationship between the basicity of the ribonuclease molecule and the degradation of double spiral RNA: recent contribution] 67
Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain. 67
Extracellular Matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome 66
[Structure-dependent differential susceptibility of poly(A) to pancreatic ribonuclease and to ribonuclease BS-1] 65
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 63
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 63
Oncometabolites in cancer aggressiveness and tumour repopulation 62
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB 61
Structure of the bovine pancreatic ribonuclease gene: the unique intervening sequence in the 5' untraslated region contains a promoter-like element. 59
Molecular evolution of genes encoding ribonucleases in ruminant species. 57
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 57
Progressively de-differentiated pancreatic cancer cells shift from glycolysis to oxidative metabolism and gain a quiescent stem state 56
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 54
Interaction of the nuclear protein CBF1 with the kB site of the IL-6 gene promoter. 52
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate‑copper complex loaded into hyaluronic acid decorated liposomes 51
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 51
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 49
Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development 49
Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells 45
Mitochondrial Elongation and OPA1 Play Crucial Roles during the Stemness Acquisition Process in Pancreatic Ductal Adenocarcinoma 42
Regulation of succinate dehydrogenase and role of succinate in cancer 37
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 13
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 12
Totale 7.698
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.113
article - articoli 19.465
book - libri 0
conference - conferenze 1.648
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019130 0 0 0 0 0 0 0 0 0 0 72 58
2019/2020903 123 23 5 71 147 112 59 74 48 97 52 92
2020/2021895 165 121 30 83 87 93 16 62 64 8 132 34
2021/2022810 109 173 18 59 36 26 31 42 33 20 79 184
2022/20231.685 122 182 143 315 152 341 25 111 190 54 34 16
2023/2024600 31 77 46 98 90 150 18 47 9 34 0 0
Totale 7.698